GLP-1s, or glucagon-like peptide-1 receptor agonists, are safe and effective
This hormone helps boost insulin secretion (when glucose levels are high) and insulin sensitivity, enhances fat metabolism, and improves energy balance, leading to greater weight loss than single receptor drugs such as semaglutide (Ozempic and Wegovy), liraglutide, and dulaglutide
Effective protocols typically involve: To reduce autoimmune reactivity, restore tolerance, and reinforce the blood-brain barrier: Children and patients with extreme sensitivity often require: Identifying which patients are most likely to benefit from neuroimmune-focused functional testing can streamline clinical decision-making and accelerate outcomes
If conclusively proven, this may help to explain the rapid rise is diabetes and metabolic disturbances, and offer the possibility of more specifically treating the underlying dysfunctions
This is a big deal for the millions of Americans currently using compounded versions of these medications for weight loss